Metastatic Breast Cancer Global Clinical Trials Review, Q4, 2010


#41547

N/A

GlobalData

$ 1000

In Stock

 

GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, Q4, 2010"" provides data on the Metastatic Breast Cancer clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Metastatic Breast Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Metastatic Breast Cancer). 

 

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. 

 

Scope

  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
  • Overview of the enrollment pattern by phase for the past decade
  • Number of clinical trials segmented by key drugs
  • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
  • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others

Reasons to buy

  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4
List of Figures 6
Introduction 7
Metastatic Breast Cancer 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Unaccomplished Trials of Metastatic Breast Cancer 20
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Prominent Sponsors 28
Top Companies Participating in Metastatic Breast Cancer Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Eli Lilly and Company 36
Clinical Trial Overview of Eli Lilly and Company 36
Bristol-Myers Squibb Company 38
Clinical Trial Overview of Bristol-Myers Squibb Company 38
Novartis AG 40
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Pfizer Inc. 41
Clinical Trial Overview of Pfizer Inc. 41
AstraZeneca PLC 42
Clinical Trial Overview of AstraZeneca PLC 42
Abraxis BioScience, Inc. 43
Clinical Trial Overview of Abraxis BioScience, Inc. 43
F. Hoffmann-La Roche Ltd. 44
F. Hoffmann-La Roche Ltd. 44
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 44
Amgen Inc. 47
Clinical Trial Overview of Amgen Inc. 47
AstraZeneca Pharmaceuticals, LP 48
Clinical Trial Overview of AstraZeneca Pharmaceuticals, LP 48
Sanofi-Aventis 49
Clinical Trial Overview of Sanofi-Aventis 49
Johnson & Johnson 50
Clinical Trial Overview of Johnson & Johnson 50
US Oncology, Inc. 51
Clinical Trial Overview of US Oncology, Inc. 51
Fresenius Biotech GmbH 52
Clinical Trial Overview of Fresenius Biotech GmbH 52
Boehringer Ingelheim GmbH 53
Clinical Trial Overview of Boehringer Ingelheim GmbH 53
YM BioSciences Inc. 54
YM BioSciences Inc. 54
Clinical Trial Overview of YM BioSciences Inc. 54
Taiho Pharmaceutical Co., Ltd. 55
Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd. 55
Bayer AG 56
Clinical Trial Overview of Bayer AG 56
Clinical Trial Overview of Top Universities / Institutes / Hospitals 57
National Cancer Institute (NCI) 57
Clinical Trial Overview of National Cancer Institute (NCI) 57
The University of Texas M. D. Anderson Cancer Center 65
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 65
Memorial Sloan Kettering Cancer Center 68
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 68
Dana-Farber Cancer Institute 69
Clinical Trial Overview of Dana-Farber Cancer Institute 69
Fred Hutchinson Cancer Research Center-Technology Transfer 70
Clinical Trial Overview of Fred Hutchinson Cancer Research Center-Technology Transfer 70
Southeastern Medical Oncology Center 71
Clinical Trial Overview of Southeastern Medical Oncology Center 71
Sidney Kimmel Comprehensive Cancer Center 72
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 72
FUDAN University 73
Clinical Trial Overview of FUDAN University 73
Sarah Cannon Research Institute 74
Clinical Trial Overview of Sarah Cannon Research Institute 74
Stanford University 75
Clinical Trial Overview of Stanford University 75
Albert Einstein College of Medicine of Yeshiva University 76
Clinical Trial Overview of Albert Einstein College of Medicine of Yeshiva University 76
The Vanderbilt-Ingram Cancer Center 77
Clinical Trial Overview of The Vanderbilt-Ingram Cancer Center 77
Mayo Clinic 78
Clinical Trial Overview of Mayo Clinic 78
Cancer Prevention Institute of California 79
Clinical Trial Overview of Cancer Prevention Institute of California 79
University of Wisconsin Madison 80
Clinical Trial Overview of University of Wisconsin Madison 80
Fox Chase Cancer Center 81
Clinical Trial Overview of Fox Chase Cancer Center 81
Washington University School of Medicine 82
Clinical Trial Overview of Washington University School of Medicine 82
University of Medicine and Dentistry New Jersey 83
Clinical Trial Overview of University of Medicine and Dentistry New Jersey 83
Duke University 84
Clinical Trial Overview of Duke University 84
Roswell Park Cancer Institute 85
Clinical Trial Overview of Roswell Park Cancer Institute 85

Appendix 86
Abbreviations 86
Definitions 86
Research Methodology 87
Secondary Research 87
About GlobalData 88
Contact Us 88
Disclaimer 88
Source 88


Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2010* 8
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2010* 9
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2010* 10
Metastatic Breast Cancer Therapeutics Clinical Trials, Asia-Pacific , Top Five Countries, 2010* 11
Metastatic Breast Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2010* 12
Metastatic Breast Cancer Therapeutics Clinical Trials, North America, Top Countries, 2010* 13
Metastatic Breast Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2010* 14
Metastatic Breast Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2010* 15
Metastatic Breast Cancer Therapeutics Clinical Trials, BRIC Countries, 2010* 16
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2010* 17
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials in Progress by Phase 2010* 18
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 19
Metastatic Breast Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2010* 20
Metastatic Breast Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2010* 21
Metastatic Breast Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2010* 22
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 29
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010* 31
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2010** 32
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2010* 33
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2010* 36
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2010* 38
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2010* 40
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2010* 41
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2010* 42
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abraxis BioScience, Inc., 2010* 43
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2010* 44
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2010* 47
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Pharmaceuticals, LP, 2010* 48
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-Aventis, 2010* 49
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2010* 50
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by US Oncology, Inc., 2010* 51
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fresenius Biotech GmbH, 2010* 52
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2010* 53
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by YM BioSciences Inc., 2010* 54
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2010* 55
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2010* 56
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute (NCI), 2010* 57
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2010* 65
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2010* 68
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2010* 69
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center-Technology Transfer, 2010* 70
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeastern Medical Oncology Center, 2010* 71
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2010* 72
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2010* 73
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2010* 74
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2010* 75
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert Einstein College of Medicine of Yeshiva University, 2010* 76
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Vanderbilt-Ingram Cancer Center, 2010* 77
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2010* 78
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Prevention Institute of California, 2010* 79
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2010* 80
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2010* 81
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2010* 82
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2010* 83
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2010* 84
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2010* 85


Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2010* 8
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2010* 9
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2010* 10
Metastatic Breast Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2010* 11
Metastatic Breast Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2010* 12
Metastatic Breast Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2010* 13
Metastatic Breast Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2010* 14
Metastatic Breast Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2010* 15
Metastatic Breast Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2010* 16
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2010* 17
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2010* 18
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 19
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 28
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010* 30
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2010* 32
GlobalData Methodology 87